AstraZeneca PLC
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| AZN.L | PFE | MRK | NVS | GLAXO.BO | LLY.NE | |
|---|---|---|---|---|---|---|
| Market cap | 218.15B | 175.50B | 370.96B | 311.59B | 423.63B | 1.74T |
| P/E (TTM) | 26.7 | 44.0 | 151.9 | 31.5 | 44.4 | 65.7 |
| Forward P/E | 16.6 | 10.6 | 16.7 | 16.6 | 36.9 | — |
| Price/book | 5.6 | 2.1 | 8.9 | 8.4 | 24.8 | 1.4 |
| Dividend yield | 1.70% | 5.59% | 2.26% | 2.87% | 1.75% | 0.58% |
| 1-year change | +9.27% | +23.90% | +75.29% | +30.35% | +6.17% | +35.37% |
| Today | +0.30% | +2.63% | +3.93% | +3.59% | −1.26% | +0.78% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All AZN.L news ›AstraZeneca made $10 billion offer for obesity drugmaker Rhythm, sources say
By Sabrina Valle, Milana Vinn and Amy-Jo Crowley Nov 4 (Reuters) - AstraZeneca made an offer of about $10 billion to acquire obesity drugmaker Rhythm Pharmaceuticals, according to three people familiar with the matter. AstraZeneca offered…
More from 1 other outlet
AstraZeneca Filing Accepted in Europe and Japan for Lung Cancer
AstraZeneca’s regulatory filings for a TAGRISSO and ORPATHYS combination have been accepted in Europe and Japan for a form of non-small cell lung cancer. The… AstraZeneca (LSE:AZN) said its filings for the TAGRISSO plus ORPATHYS regimen…
RYTM Stock Clocks Best Day In Nearly 16 Months On AstraZeneca $10B Bid Report
Shares of Rhythm Pharmaceuticals (RYTM) closed up 28% on Wednesday, clocking its best day since July 2025, following reports that U.K-based pharma giant AstraZeneca had submitted a roughly $10 billion takeover proposal for it. According to…
AstraZeneca appoints Naveen Krishna Yamarthi as Managing Director, AstraZeneca India Private Limited (AZIPL) and Head of Global Innovation & Technology Centre, Chennai
Chennai, 04 November 2026: AstraZeneca announced the appointment of Naveen Krishna Yamarthi as Managing Director AZIPL and Head of its Global Innovation & Technology Centre (GITC), Chennai, effective 30 October 2026. In this role, Naveen…
OncoC4 Appoints Former AstraZeneca Executive Dan Janiak As Chief Business Officer
OncoC4, a clinical-stage biotechnology company developing cancer and immunology treatments, has appointed Dan Janiak, Ph.D., as Chief Business Officer. Janiak brings more than 15 years of experience in biotechnology financing, corporate…
Why Did AstraZeneca (LSE:AZN) Stock Jump After Its Cost-Savings Reset This Week?
Ecora Royalties (LSE:ECOR) Gets Cobalt Boost Below FTSE 100 Vanquis (LSE:VANQ) Rebuilds Returns Below the FTSE 100 Big Technologies (LSE:BIG) Braces for a Legal Fight Raspberry Pi (LSE:RPI) Founder Buys In Below the FTSE 100 The…
Gastric Cancer Market to Expand Rapidly by 2035 Amid Increasing Investments and Innovation | AstraZeneca, Daiichi Sankyo, Bristol-Myers Squibb, Amgen, Jazz Pharma, BeiGene, Zymeworks, ALX Oncology
Gastric Cancer Market to Expand Rapidly by 2035 Amid Increasing openPR.com Gastric Cancer Market to Expand Rapidly by 2035 Amid Increasing Investments and Innovation | AstraZeneca, Daiichi Sankyo, Bristol-Myers Squibb, Amgen, Jazz Pharma,…
Boehringer Ingelheim and SBP Group enter partnership to advance next-generation cancer therapies
Cancer remains one of the world’s greatest health challenges, with approximately 20.6 million new cases and close to 10 million deaths annually. ADCs are designed to deliver potent therapeutic agents more selectively to cancer cells, while…
Cutaneous Lupus Erythematosus Pipeline Analysis 2026: Phase III and Phase II Assets, MOA Breakdown, and ROA Trends | Biogen, Horizon Therapeutics, Bristol-Myers Squibb, AstraZeneca, Sanofi, Amgen
Albany New York November 03 2026 As per DelveInsight s assessment globally Cutaneous Lupus Erythematosus pipeline constitutes 8 key companies continuously working towards developing 10 Cutaneous Lupus Erythematosus treatment therapies…
Nordic stocks in North America - AstraZeneca fell 1.0 percent
Stockholm New York New York Diff... Nordic stocks in North America - AstraZeneca fell 1.0 percent Published on 11/04/2026 at 12:52 am EST Stocks mentioned in the article Latest news about Nokia Oyj Income Statement and Estimates The more…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com83
- tradingview.com13
- seekingalpha.com10
- statnews.com8
- defenseworld.net7
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.